Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Noonan Syndrome | 22 | 2023 | 122 | 3.960 |
Why?
|
Heart Defects, Congenital | 23 | 2023 | 4584 | 1.210 |
Why?
|
Trisomy | 3 | 2017 | 266 | 1.000 |
Why?
|
Abnormalities, Multiple | 10 | 2020 | 1416 | 0.900 |
Why?
|
Cardiomyopathy, Dilated | 5 | 2020 | 851 | 0.690 |
Why?
|
Genetic Testing | 13 | 2023 | 3444 | 0.650 |
Why?
|
Smith-Lemli-Opitz Syndrome | 1 | 2017 | 46 | 0.600 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2017 | 197 | 0.590 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 10 | 2018 | 234 | 0.580 |
Why?
|
DNA Mutational Analysis | 11 | 2020 | 4186 | 0.570 |
Why?
|
Barth Syndrome | 2 | 2014 | 25 | 0.550 |
Why?
|
Cardiomyopathy, Hypertrophic | 6 | 2023 | 1265 | 0.530 |
Why?
|
Executive Function | 4 | 2023 | 1364 | 0.530 |
Why?
|
SOS1 Protein | 5 | 2013 | 41 | 0.520 |
Why?
|
Ectodermal Dysplasia | 4 | 2023 | 106 | 0.470 |
Why?
|
Growth Charts | 1 | 2012 | 61 | 0.420 |
Why?
|
LEOPARD Syndrome | 2 | 2023 | 14 | 0.400 |
Why?
|
Failure to Thrive | 3 | 2023 | 136 | 0.390 |
Why?
|
DiGeorge Syndrome | 3 | 2017 | 177 | 0.370 |
Why?
|
Siblings | 1 | 2014 | 854 | 0.360 |
Why?
|
Intelligence | 2 | 2014 | 920 | 0.360 |
Why?
|
Facies | 4 | 2023 | 197 | 0.330 |
Why?
|
Mutation | 18 | 2020 | 29786 | 0.320 |
Why?
|
Protein Tyrosine Phosphatases | 4 | 2007 | 473 | 0.310 |
Why?
|
DNA Copy Number Variations | 5 | 2023 | 1941 | 0.290 |
Why?
|
Induced Pluripotent Stem Cells | 4 | 2019 | 1736 | 0.280 |
Why?
|
Genetic Predisposition to Disease | 8 | 2020 | 17446 | 0.280 |
Why?
|
ras Proteins | 5 | 2022 | 1060 | 0.260 |
Why?
|
Phenotype | 15 | 2020 | 16365 | 0.260 |
Why?
|
Mutation, Missense | 5 | 2024 | 2564 | 0.250 |
Why?
|
Genetic Association Studies | 7 | 2015 | 2703 | 0.240 |
Why?
|
Tetralogy of Fallot | 2 | 2021 | 623 | 0.240 |
Why?
|
Aortic Stenosis, Supravalvular | 1 | 2024 | 30 | 0.240 |
Why?
|
Memory | 2 | 2013 | 2174 | 0.240 |
Why?
|
Learning | 1 | 2013 | 1713 | 0.230 |
Why?
|
Chondroitinsulfatases | 1 | 2023 | 16 | 0.230 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2004 | 326 | 0.230 |
Why?
|
Child | 32 | 2024 | 77709 | 0.230 |
Why?
|
Germ-Line Mutation | 3 | 2010 | 1788 | 0.230 |
Why?
|
Musculoskeletal Abnormalities | 1 | 2024 | 95 | 0.220 |
Why?
|
Infant | 17 | 2023 | 35136 | 0.220 |
Why?
|
Nucleic Acid Hybridization | 1 | 2004 | 1375 | 0.220 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2011 | 2649 | 0.210 |
Why?
|
Costello Syndrome | 1 | 2022 | 19 | 0.210 |
Why?
|
Child, Preschool | 19 | 2023 | 41006 | 0.210 |
Why?
|
Williams Syndrome | 1 | 2024 | 187 | 0.200 |
Why?
|
Acidosis, Lactic | 1 | 2023 | 142 | 0.200 |
Why?
|
Rare Diseases | 2 | 2024 | 553 | 0.200 |
Why?
|
Chromosome Deletion | 2 | 2016 | 1401 | 0.200 |
Why?
|
Adolescent | 26 | 2023 | 85781 | 0.190 |
Why?
|
Chromosome Aberrations | 3 | 2014 | 1813 | 0.190 |
Why?
|
Intracellular Signaling Peptides and Proteins | 6 | 2012 | 2915 | 0.180 |
Why?
|
MAP Kinase Kinase 1 | 2 | 2019 | 337 | 0.180 |
Why?
|
Cardiomyopathies | 2 | 2023 | 1912 | 0.180 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2019 | 96 | 0.170 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2019 | 66 | 0.170 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 3658 | 0.170 |
Why?
|
Humans | 75 | 2024 | 744343 | 0.170 |
Why?
|
Spasms, Infantile | 1 | 2022 | 305 | 0.170 |
Why?
|
Muscular Diseases | 1 | 2023 | 556 | 0.160 |
Why?
|
Cerebrum | 1 | 2020 | 137 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2019 | 203 | 0.160 |
Why?
|
Developmental Disabilities | 4 | 2024 | 1456 | 0.160 |
Why?
|
Growth Differentiation Factor 1 | 1 | 2017 | 6 | 0.160 |
Why?
|
Epilepsy | 2 | 2023 | 3310 | 0.150 |
Why?
|
Heart | 5 | 2023 | 4467 | 0.150 |
Why?
|
Cardiac Myosins | 1 | 2017 | 117 | 0.150 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2017 | 118 | 0.150 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2017 | 245 | 0.150 |
Why?
|
Cataract | 1 | 2023 | 834 | 0.150 |
Why?
|
Genes, ras | 2 | 2010 | 690 | 0.150 |
Why?
|
Male | 41 | 2023 | 350118 | 0.140 |
Why?
|
Chromosome Disorders | 2 | 2017 | 514 | 0.140 |
Why?
|
Tissue Engineering | 2 | 2019 | 1880 | 0.140 |
Why?
|
Genotype | 9 | 2022 | 12951 | 0.140 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2022 | 2043 | 0.140 |
Why?
|
Chylothorax | 1 | 2017 | 84 | 0.140 |
Why?
|
Heterozygote | 2 | 2020 | 2804 | 0.140 |
Why?
|
Son of Sevenless Proteins | 1 | 2015 | 27 | 0.140 |
Why?
|
Myosin Heavy Chains | 1 | 2017 | 414 | 0.130 |
Why?
|
Craniofacial Abnormalities | 2 | 2010 | 315 | 0.130 |
Why?
|
Echocardiography | 4 | 2020 | 5102 | 0.130 |
Why?
|
Glucose Transporter Type 3 | 1 | 2015 | 16 | 0.130 |
Why?
|
Myocytes, Cardiac | 3 | 2019 | 1637 | 0.130 |
Why?
|
Female | 38 | 2023 | 380194 | 0.130 |
Why?
|
Nuclear Matrix-Associated Proteins | 1 | 2015 | 45 | 0.130 |
Why?
|
MAP Kinase Signaling System | 3 | 2014 | 1526 | 0.130 |
Why?
|
Fatal Outcome | 2 | 2017 | 1850 | 0.120 |
Why?
|
Muscle Proteins | 1 | 2020 | 1159 | 0.120 |
Why?
|
Nervous System Malformations | 1 | 2015 | 247 | 0.120 |
Why?
|
Infant, Newborn | 6 | 2023 | 25625 | 0.120 |
Why?
|
Syndrome | 5 | 2022 | 3251 | 0.110 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2015 | 209 | 0.110 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2015 | 474 | 0.110 |
Why?
|
Protein Kinases | 1 | 2020 | 1640 | 0.110 |
Why?
|
Therapies, Investigational | 1 | 2014 | 112 | 0.110 |
Why?
|
Aortic Coarctation | 1 | 2015 | 281 | 0.110 |
Why?
|
Fetal Distress | 1 | 2012 | 40 | 0.110 |
Why?
|
Nuchal Translucency Measurement | 1 | 2012 | 56 | 0.100 |
Why?
|
Angiography | 1 | 2017 | 1639 | 0.100 |
Why?
|
Heart Ventricles | 3 | 2015 | 3821 | 0.100 |
Why?
|
Hand Deformities, Congenital | 1 | 2012 | 146 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1678 | 0.100 |
Why?
|
Tachycardia, Ventricular | 1 | 2019 | 1273 | 0.090 |
Why?
|
Mitochondrial Diseases | 1 | 2014 | 320 | 0.090 |
Why?
|
Heart Transplantation | 2 | 2020 | 3110 | 0.090 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2017 | 1222 | 0.090 |
Why?
|
Prognosis | 4 | 2021 | 29063 | 0.090 |
Why?
|
Fontan Procedure | 1 | 2015 | 778 | 0.090 |
Why?
|
Arrhythmias, Cardiac | 1 | 2019 | 2268 | 0.090 |
Why?
|
Aniridia | 1 | 2009 | 37 | 0.090 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1708 | 0.080 |
Why?
|
Neurogenesis | 1 | 2015 | 838 | 0.080 |
Why?
|
RNA-Binding Proteins | 2 | 2015 | 1903 | 0.080 |
Why?
|
Chromosomes, Human, Pair 15 | 2 | 2020 | 373 | 0.080 |
Why?
|
Disease Management | 3 | 2014 | 2459 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2017 | 3597 | 0.080 |
Why?
|
Young Adult | 9 | 2021 | 56430 | 0.080 |
Why?
|
Microarray Analysis | 1 | 2011 | 767 | 0.080 |
Why?
|
Branchio-Oto-Renal Syndrome | 1 | 2008 | 24 | 0.080 |
Why?
|
Cognition Disorders | 2 | 2015 | 4043 | 0.080 |
Why?
|
Adult | 18 | 2023 | 214055 | 0.080 |
Why?
|
Transcription Factor AP-2 | 1 | 2008 | 82 | 0.080 |
Why?
|
Autistic Disorder | 1 | 2017 | 1185 | 0.080 |
Why?
|
Neck | 1 | 2012 | 697 | 0.080 |
Why?
|
Cohort Studies | 6 | 2022 | 40561 | 0.080 |
Why?
|
Karyotyping | 2 | 2011 | 1243 | 0.070 |
Why?
|
Heart Valve Diseases | 1 | 2015 | 1073 | 0.070 |
Why?
|
Quantitative Trait Loci | 1 | 2014 | 2019 | 0.070 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2009 | 223 | 0.070 |
Why?
|
Environment | 1 | 2012 | 1124 | 0.070 |
Why?
|
Infant, Premature, Diseases | 1 | 2012 | 706 | 0.070 |
Why?
|
Activin Receptors, Type I | 1 | 2006 | 142 | 0.070 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2007 | 97 | 0.070 |
Why?
|
Nuclear Proteins | 2 | 2012 | 5853 | 0.070 |
Why?
|
Retrospective Studies | 6 | 2023 | 77449 | 0.070 |
Why?
|
Genetic Variation | 2 | 2019 | 6544 | 0.070 |
Why?
|
Genome-Wide Association Study | 3 | 2024 | 12261 | 0.070 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2011 | 574 | 0.070 |
Why?
|
Cardiomegaly | 1 | 2008 | 620 | 0.060 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2006 | 314 | 0.060 |
Why?
|
Prenatal Diagnosis | 1 | 2012 | 1236 | 0.060 |
Why?
|
Risk Factors | 4 | 2022 | 72290 | 0.060 |
Why?
|
Cardiovascular Diseases | 3 | 2019 | 15165 | 0.060 |
Why?
|
Aortic Valve | 1 | 2015 | 1922 | 0.060 |
Why?
|
Translocation, Genetic | 2 | 2015 | 1420 | 0.060 |
Why?
|
Models, Molecular | 3 | 2015 | 5456 | 0.060 |
Why?
|
Cardiovascular System | 1 | 2012 | 832 | 0.060 |
Why?
|
Models, Biological | 2 | 2014 | 9583 | 0.060 |
Why?
|
Retinaldehyde | 1 | 2003 | 25 | 0.060 |
Why?
|
Neuropsychological Tests | 4 | 2021 | 6993 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15076 | 0.060 |
Why?
|
Attention | 1 | 2014 | 2400 | 0.060 |
Why?
|
Amino Acid Transport System y+L | 1 | 2023 | 17 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2020 | 19905 | 0.060 |
Why?
|
Sequence Deletion | 1 | 2008 | 1526 | 0.060 |
Why?
|
Brain | 4 | 2021 | 26385 | 0.060 |
Why?
|
Rod Opsins | 1 | 2003 | 111 | 0.060 |
Why?
|
Rhodopsin | 1 | 2003 | 203 | 0.060 |
Why?
|
Dark Adaptation | 1 | 2003 | 219 | 0.050 |
Why?
|
Histones | 1 | 2013 | 2599 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2014 | 12959 | 0.050 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2004 | 535 | 0.050 |
Why?
|
Spasm | 1 | 2022 | 121 | 0.050 |
Why?
|
Chromatin | 3 | 2023 | 2934 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2017 | 3537 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2022 | 1285 | 0.050 |
Why?
|
Antiporters | 1 | 2023 | 277 | 0.050 |
Why?
|
Aortic Aneurysm | 1 | 2006 | 643 | 0.050 |
Why?
|
Comparative Genomic Hybridization | 2 | 2014 | 496 | 0.050 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2023 | 440 | 0.050 |
Why?
|
Aneuploidy | 1 | 2004 | 530 | 0.050 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2023 | 437 | 0.050 |
Why?
|
Language | 1 | 2010 | 1471 | 0.050 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 25043 | 0.050 |
Why?
|
Seizures | 2 | 2023 | 2859 | 0.050 |
Why?
|
Comorbidity | 1 | 2014 | 10388 | 0.050 |
Why?
|
Transcription Factors | 2 | 2024 | 12208 | 0.040 |
Why?
|
Time Factors | 2 | 2020 | 40075 | 0.040 |
Why?
|
Heart Diseases | 1 | 2013 | 2788 | 0.040 |
Why?
|
Massachusetts | 1 | 2012 | 8663 | 0.040 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2421 | 0.040 |
Why?
|
Growth Disorders | 1 | 2004 | 645 | 0.040 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2020 | 323 | 0.040 |
Why?
|
Desmoplakins | 1 | 2019 | 62 | 0.040 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2019 | 104 | 0.040 |
Why?
|
Neonatal Screening | 1 | 2023 | 591 | 0.040 |
Why?
|
Age of Onset | 2 | 2020 | 3271 | 0.040 |
Why?
|
Face | 1 | 2004 | 994 | 0.040 |
Why?
|
Mammals | 1 | 2024 | 1143 | 0.040 |
Why?
|
Telomere | 1 | 2004 | 910 | 0.040 |
Why?
|
Light | 1 | 2003 | 1374 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2019 | 19229 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7279 | 0.040 |
Why?
|
Registries | 1 | 2012 | 8089 | 0.040 |
Why?
|
Mitochondria | 1 | 2009 | 3520 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2012 | 13989 | 0.030 |
Why?
|
Drosophila | 1 | 2024 | 1491 | 0.030 |
Why?
|
Signal Transduction | 3 | 2022 | 23403 | 0.030 |
Why?
|
DNA-Binding Proteins | 2 | 2015 | 9648 | 0.030 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2017 | 403 | 0.030 |
Why?
|
Electrocardiography | 2 | 2020 | 6442 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2021 | 21746 | 0.030 |
Why?
|
Prevalence | 1 | 2012 | 15226 | 0.030 |
Why?
|
Pedigree | 2 | 2017 | 4644 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39050 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2023 | 1224 | 0.030 |
Why?
|
Ethics, Medical | 1 | 2000 | 792 | 0.030 |
Why?
|
Proteins | 1 | 2010 | 6103 | 0.030 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2016 | 351 | 0.030 |
Why?
|
Odds Ratio | 2 | 2020 | 9849 | 0.030 |
Why?
|
Reactive Oxygen Species | 2 | 2014 | 2077 | 0.030 |
Why?
|
Leukemia, Myelomonocytic, Juvenile | 1 | 2014 | 20 | 0.030 |
Why?
|
Oncogene Protein v-akt | 1 | 2014 | 135 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2023 | 1916 | 0.030 |
Why?
|
Alleles | 2 | 2015 | 6933 | 0.030 |
Why?
|
Base Sequence | 2 | 2018 | 12797 | 0.030 |
Why?
|
Genes, Developmental | 1 | 2013 | 40 | 0.030 |
Why?
|
Neurofibromin 1 | 1 | 2014 | 196 | 0.030 |
Why?
|
Homozygote | 1 | 2017 | 1785 | 0.030 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2014 | 261 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2017 | 1997 | 0.030 |
Why?
|
Acyltransferases | 1 | 2014 | 294 | 0.030 |
Why?
|
Mutagenesis, Insertional | 1 | 2015 | 655 | 0.030 |
Why?
|
Action Potentials | 1 | 2019 | 1806 | 0.030 |
Why?
|
Educational Status | 2 | 2010 | 2540 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2017 | 15519 | 0.020 |
Why?
|
Smith-Magenis Syndrome | 1 | 2011 | 19 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 625 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2013 | 5867 | 0.020 |
Why?
|
Magnetics | 1 | 2014 | 606 | 0.020 |
Why?
|
RNA Splicing | 1 | 2015 | 907 | 0.020 |
Why?
|
Chromosome Duplication | 1 | 2011 | 74 | 0.020 |
Why?
|
Dyslexia, Acquired | 1 | 2010 | 14 | 0.020 |
Why?
|
Genetic Diseases, Inborn | 1 | 2015 | 587 | 0.020 |
Why?
|
Articulation Disorders | 1 | 2010 | 14 | 0.020 |
Why?
|
DNA | 1 | 2005 | 7301 | 0.020 |
Why?
|
Congenital Abnormalities | 1 | 2015 | 707 | 0.020 |
Why?
|
Proteomics | 1 | 2024 | 3638 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2015 | 1791 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2634 | 0.020 |
Why?
|
Methylation | 1 | 2013 | 1106 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4204 | 0.020 |
Why?
|
Heart Failure | 1 | 2014 | 10900 | 0.020 |
Why?
|
Animals | 7 | 2024 | 168757 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2012 | 528 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6538 | 0.020 |
Why?
|
Electron Transport Complex IV | 1 | 2009 | 189 | 0.020 |
Why?
|
Chromosomes, Human | 1 | 2011 | 457 | 0.020 |
Why?
|
Parents | 1 | 2023 | 3407 | 0.020 |
Why?
|
Language Disorders | 1 | 2010 | 141 | 0.020 |
Why?
|
Pregnancy | 3 | 2022 | 29144 | 0.020 |
Why?
|
Sarcomeres | 1 | 2012 | 374 | 0.020 |
Why?
|
Cytochromes c | 1 | 2009 | 180 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2012 | 13815 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2015 | 1082 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2012 | 498 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2017 | 3920 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2014 | 1585 | 0.020 |
Why?
|
Motor Skills Disorders | 1 | 2008 | 90 | 0.020 |
Why?
|
Mitochondrial Membranes | 1 | 2009 | 175 | 0.020 |
Why?
|
Lysine | 1 | 2013 | 1007 | 0.020 |
Why?
|
Age Factors | 2 | 2019 | 18370 | 0.020 |
Why?
|
Epigenomics | 1 | 2014 | 903 | 0.020 |
Why?
|
Cell Separation | 1 | 2014 | 1751 | 0.020 |
Why?
|
Gene Silencing | 1 | 2015 | 1538 | 0.020 |
Why?
|
Medical History Taking | 1 | 2012 | 783 | 0.020 |
Why?
|
Genetic Loci | 1 | 2017 | 2575 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 35421 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2012 | 18111 | 0.020 |
Why?
|
Gene Frequency | 1 | 2014 | 3588 | 0.020 |
Why?
|
COS Cells | 1 | 2009 | 1161 | 0.020 |
Why?
|
Oxidative Phosphorylation | 1 | 2009 | 481 | 0.020 |
Why?
|
Protein Conformation | 1 | 2015 | 4011 | 0.020 |
Why?
|
Motor Skills | 1 | 2010 | 522 | 0.020 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2008 | 380 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5720 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2886 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2013 | 1341 | 0.020 |
Why?
|
Collagen Type III | 1 | 2006 | 90 | 0.020 |
Why?
|
Hearing | 1 | 2010 | 482 | 0.020 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2011 | 615 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2014 | 4740 | 0.020 |
Why?
|
Reading | 1 | 2010 | 558 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2009 | 1137 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1866 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4803 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2000 | 3923 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2012 | 14557 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12354 | 0.020 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2006 | 89 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2012 | 1783 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2009 | 2839 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9687 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2021 | 5708 | 0.020 |
Why?
|
Caenorhabditis elegans | 1 | 2014 | 1419 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2015 | 3023 | 0.020 |
Why?
|
Gene Expression | 1 | 2017 | 7799 | 0.020 |
Why?
|
Cell Line | 1 | 2018 | 15997 | 0.020 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2006 | 272 | 0.010 |
Why?
|
Mice | 4 | 2015 | 81183 | 0.010 |
Why?
|
Hemodynamics | 1 | 2014 | 4199 | 0.010 |
Why?
|
Infant, Premature | 1 | 2012 | 2044 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2008 | 2421 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2009 | 3846 | 0.010 |
Why?
|
Reference Values | 1 | 2009 | 4982 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2003 | 876 | 0.010 |
Why?
|
Kinetics | 1 | 2009 | 6473 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2015 | 7722 | 0.010 |
Why?
|
Transfection | 1 | 2009 | 5892 | 0.010 |
Why?
|
Arteries | 1 | 2006 | 1119 | 0.010 |
Why?
|
Hearing Loss | 1 | 2008 | 765 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 13033 | 0.010 |
Why?
|
Middle Aged | 4 | 2023 | 213383 | 0.010 |
Why?
|
Echocardiography, Transesophageal | 1 | 2006 | 1133 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2010 | 2576 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 53288 | 0.010 |
Why?
|
Myocardium | 1 | 2012 | 4776 | 0.010 |
Why?
|
Fibroblasts | 1 | 2009 | 4161 | 0.010 |
Why?
|
Dyspnea | 1 | 2006 | 1303 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2012 | 5021 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8436 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2014 | 3523 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2023 | 57776 | 0.010 |
Why?
|
Photic Stimulation | 1 | 2003 | 2025 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13284 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2009 | 4665 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9438 | 0.010 |
Why?
|
Survival Analysis | 1 | 2006 | 10252 | 0.010 |
Why?
|
Cognition | 1 | 2010 | 6770 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 2006 | 2861 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 20947 | 0.010 |
Why?
|
United States | 2 | 2014 | 69872 | 0.010 |
Why?
|
Aged | 1 | 2023 | 163280 | 0.010 |
Why?
|
Students, Medical | 1 | 2000 | 1862 | 0.000 |
Why?
|
Physicians | 1 | 2000 | 4567 | 0.000 |
Why?
|
Internship and Residency | 1 | 2000 | 5788 | 0.000 |
Why?
|